Bio-Chem Pharma (BCHXF) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bio-Chem Pharma (BCHXF)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Stopforth who wrote (27)	10/5/1996 11:18:00 AM
From: John Stopforth	of 43

Liver drug boost for BioChem Story in the Financial Post states the reason for the spectacular rise in Biochems shares last week (up $4 on the Nasdaq) is the drug Lamivudine. The story says the drug may be more effective than was anticipated. John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next